Livforsakringsbolaget Skandia’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$5K 599
2022
Q3
$5K Sell
200
-900
-82% -$31.6K ﹤0.01% 570
2022
Q2
$37K Sell
1,100
-700
-39% -$29.7K ﹤0.01% 566
2022
Q1
$130K Hold
1,800
0.01% 534
2021
Q4
$165K Hold
1,800
0.01% 523
2021
Q3
$228K Hold
1,800
0.01% 492
2021
Q2
$299K Hold
1,800
0.02% 480
2021
Q1
$327K Hold
1,800
0.02% 402
2020
Q4
$360K Buy
1,800
+1,000
+125% +$203K 0.03% 371
2020
Q3
$175K Hold
800
0.02% 411
2020
Q2
$153K Buy
+800
New +$140K 0.02% 426

Other funds holding TDOC

Livforsakringsbolaget Skandia's TDOC Position: Q4 2022 in Review

Livforsakringsbolaget Skandia sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 200 shares — an estimated $5K sold.

Livforsakringsbolaget Skandia first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $360K in Q4 2020. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Livforsakringsbolaget Skandia reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 200 Teladoc Health shares in Q4 2022, an estimated $5K.
  • Livforsakringsbolaget Skandia first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Livforsakringsbolaget Skandia's Teladoc Health position peaked at $360K in Q4 2020.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.